|
1.
|
Are C and Shaha AR: Anaplastic thyroid
carcinoma: biology, pathogenesis, prognostic factors and treatment
approaches. Ann Surg Oncol. 13:453–464. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Jordan CT, Guzman ML and Noble M: Cancer
stem cells. N Engl J Med. 355:1253–1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Ward RJ and Dirks PB: Cancer stem cells:
at the headwaters of tumor development. Annu Rev Pathol. 2:175–189.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Hirschmann-Jax C, Foster AE, Wulf GG,
Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct
‘side population’ of cells with high drug efflux capacity in human
tumor cells. Proc Natl Acad Sci USA. 101:14228–14233. 2004.
|
|
6.
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Re. 63:5821–5828.
2003.PubMed/NCBI
|
|
7.
|
Hemmati HD, Nakano I, Lazareff JA,
Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI:
Cancerous stem cells can arise from pediatric brain tumors. Proc
Natl Acad Sci USA. 100:15178–15183. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Ignatova TN, Kukekov VG, Laywell ED,
Suslov ON, Vrionis FD and Steindler DA: Human cortical glial tumors
contain neural stem-like cells expressing astroglial and neuronal
markers in vitro. Glia. 39:193–206. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Friedman S, Lu M, Schultz A, Thomas D and
Lin RY: CD133+ anaplastic thyroid cancer cells initiate
tumors in immunodeficient mice and are regulated by thyrotropin.
PLoS One. 4:e53952009.
|
|
11.
|
Zito G, Richiusa P, Bommarito A, Carissimi
E, Russo L, Coppola A, Zerilli M, Rodolico V, Criscimanna A, Amato
M, Pizzolanti G, Galluzzo A and Giordano C: In vitro identification
and characterization of CD133(pos) cancer stem-like cells in
anaplastic thyroid carcinoma cell lines. PLoS One. 3:e35442008.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Thomas D, Friedman S and Lin RY: Thyroid
stem cells: lessons from normal development and thyroid cancer.
Endocr Relat Cancer. 15:51–58. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Thomas T, Nowka K, Lan L and Derwahl M:
Expression of endoderm stem cell markers: evidence for the presence
of adult stem cells in human thyroid glands. Thyroid. 16:537–544.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lan L, Cui D, Nowka K and Derwahl M: Stem
cells derived from goiters in adults form spheres in response to
intense growth stimulation and require thyrotropin for
differentiation into thyrocytes. J Clin Endocrinol Metab.
92:3681–3688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Fierabracci A, Puglisi MA, Giuliani L,
Mattarocci S and Gallinella-Muzi M: Identification of an adult
stem/progenitor cell-like population in the human thyroid. J
Endocrinol. 198:471–487. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Zheng XQ, Cui D, Xu SH, Brabant G and
Dereahl M: Doxorubicin fails to eradicate cancer stem cells derived
from anaplastic thyroid carcinoma cells: characterization of
resistant cells. Int J Oncol. 37:307–315. 2010.PubMed/NCBI
|
|
17.
|
Mitsutake N, Iwao A, Nagai K, Namba H,
Ohtsuru A, Saenko V and Yamashita S: Characterization of side
population in thyroid cancer cell lines: cancer stem-like cells are
enriched partly but not exclusively. Endocrinology. 148:1797–1803.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Takano T and Amino N: Fetal cell
carcinogenesis: a new hypothesis for better understanding of
thyroid carcinoma. Thyroid. 15:432–438. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell
LL, Polyak K, Brisken C, Yang J and Weinberg RA: The epithelial
mesenchymal transition generates cells with properties of stem
cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Raimondi C, Gianni W, Cortesi E and
Gazzaniga P: Cancer stem cells and epithelial-mesenchymal
transition: revisiting minimal residual disease. Current Cancer
Drug Targets. 10:496–508. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Hollier BG, Evans K and Mani SA: The
epithelial-to-mesenchymal transition and cancer stem cells: a
coalition against cancer therapies. J Mammary Gland Biol Neoplasia.
14:29–43. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Hayashida T, Jinno H, Kitagawa Y and
Kitajima M: Cooperation of cancer stem cell properties and
epithelial-mesenchymal transition in the establishment of breast
cancer metastasis. J Oncol. 2011:5914272011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Goretzki PE, Frilling A, Simon D and
Roeher HD: Growth regulation of normal thyroids and thyroid tumors
in man. Recent Results Cancer Res. 118:48–63. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Luo Y, He DL, Ning L, Shen SL, Li L, Li X,
Zhau HE and Chung LW: Over-expression of hypoxia-inducible
factor-1alpha increases the invasive potency of LNCaP cells in
vitro. BJU Int. 98:1315–1319. 2006. View Article : Google Scholar
|
|
26.
|
Hundahl SA, Fleming ID, Fremgen AM and
Menck HR: A National Cancer Data Base report on 53,856 cases of
thyroid carcinoma treated in the U.S., 1985–1995. Cancer.
83:2638–2648. 1998.PubMed/NCBI
|
|
27.
|
Kong D, Banerjee S, Ahmad A, Li Y, Wang Z,
Sethi S and Sarkar FH: Epithelial to mesenchymal transition is
mechanistically linked with stem cell signatures in prostate cancer
cells. PLoS One. 5:e124452010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Klarmann GJ, Hurt EM, Mathews LA, Zhang X,
Duhagon MA, Mistree T, Thomas SB and Farrar WL: Invasive prostate
cancer cells are tumor initiating cells that have a stem cell-like
genomic signature. Clin Exp Metastasis. 26:433–446. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Salnikov AV, Liu L, Platen M, Gladkich J,
Salnikova O, Ryschich E, Mattern J, Moldenhauer G, Werner J,
Schemmer P, Buechler MW and Herr I: Hypoxia induces EMT in low and
highly aggressive pancreatic tumor cells but only cells with cancer
stem cell characteristics acquire pronounced migratory potential.
PLoS One. 7:e463912012. View Article : Google Scholar
|
|
31.
|
Lu X and Kang YB: Hypoxia and
hypoxia-inducible factors: master regulators of metastasis. Clin
Cancer Res. 16:5928–5935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Mimeault M and Batra SK: Hypoxia-inducing
factors as master regulators of stemness properties and altered
metabolism of cancer- and metastasis-initiating cells. J Cell Mol
Med. 17:30–54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Kim K, Lu Z and Hay ED: Direct evidence
for a role of beta-catenin/ LEF-1 signaling pathway in induction of
EMT. Cell Biol Int. 26:463–476. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Medici D, Hay ED and Olsen BR: Snail and
Slug promote epithelialmesenchymal transition through
beta-catenin-T-cell factor-4-dependent expression of transforming
growth factor-beta3. Mol Biol Cell. 19:4875–4887. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Yang L, Lin C and Liu ZR: P68 RNA helicase
mediates PDGF-induced epithelial mesenchymal transition by
displacing Axin from beta-catenin. Cell. 127:139–155. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar
|
|
38.
|
Hurt EM, Chan K, Serrat MA, Thomas SB,
Veenstra TD and Farrar WL: Identification of vitronectin as an
extrinsic inducer of cancer stem celldifferentiation and tumor
formation. Stem Cell. 28:390–398. 2010.PubMed/NCBI
|
|
39.
|
Morel AP, Lièvre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
